Description:
Kalorama Information’s United States Market for In Vitro Diagnostic (IVD) Tests, 3rd Edition provides a comprehensive and insightful analysis of the IVD market in the U.S. This market, the largest in the world, is undergoing significant changes influenced by various factors, including the profound impact of COVID-19.
Market Dynamics:
Explore the current state and future prospects of the U.S. IVD market, focusing on:
- Impact of COVID-19: Understand how the pandemic has reshaped the IVD landscape, with some segments experiencing rapid growth while others lagged. Insights are provided based on discussions with market participants and government entities, offering a realistic outlook for the COVID-19 diagnostics market through 2025.
- Aging Population: Examine how demographic aging drives demand for IVD tests, with individuals over 60 undergoing more clinical tests than younger individuals, influencing the prevalence of chronic diseases like diabetes and cancer.
Market Segments:
The report provides detailed market data and analysis for key IVD segments in the United States:
- Clinical Chemistry
- Microbiology (Traditional) – Identification and Antibiotic Susceptibility Testing (ID/AST)
- Microbiology – Molecular-Infectious Disease
- Point-of-Care (POC) Tests – Diabetes
- Point-of-Care (POC) Tests – All Other
- Immunoassays – Infectious Disease (non-POC)
- Immunoassays – Other
- Molecular – Non-infectious Disease
- Hematology
- Coagulation (non-POC)
- Histology
- Blood Testing and Typing
- Other
Industry Trends:
Discover the major trends shaping the U.S. IVD market, including:
- Technological Advancements: Innovations in diagnostic technologies and their adoption in clinical settings.
- Regulatory Environment: Changes in regulations and their impact on the market.
- Healthcare Spending: Analysis of the healthcare expenditure landscape and its influence on IVD demand.
Competitive Landscape:
Gain insights into the competitive environment with profiles of the top players in the U.S. IVD market. These profiles cover:
- Corporate Developments: Notable events and milestones from 2018 to 2020.
- Product Portfolios: Key products and innovations introduced by leading companies.
- Market Strategies: Approaches and strategies adopted by top players to maintain and expand their market presence.
Future Outlook:
This report offers projections and forecasts for the U.S. IVD market through 2025, helping stakeholders understand potential growth areas and challenges. Stay informed about the evolving landscape and make strategic decisions with Kalorama Information’s United States Market for In Vitro Diagnostic (IVD) Tests, 3rd Edition.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: U.S. IVD Market by Segment 2020-2025 (in millions $)
| Segment | 2020 | 2025 | CAGR % |
| Clinical Chemistry | $XX Million | $XX Million | XX% |
| Microbiology – ID/AST
Traditional ID/AST COVID-19 Serology |
$XX Million
$XX Million $XX Million |
$XX Million
$XX Million $XX Million |
XX%
XX% XX% |
| Microbiology – Molecular
Molecular Infectious Disease COVID-19 |
$XX Million
$XX Million $XX Million |
$XX Million
$XX Million $XX Million |
XX%
XX% XX% |
| POC Diabetes (all) | $XX Million | $XX Million | XX% |
| POC-Other | $XX Million | $XX Million | XX% |
| Immunoassay – Infectious
Immunoassay Infectious Disease COVID-19 |
$XX Million
$XX Million $XX Million |
$XX Million
$XX Million $XX Million |
XX%
XX% XX% |
| Immunoassay – Other | $XX Million | $XX Million | XX% |
| Molecular – Non-Infectious Disease | $XX Million | $XX Million | XX% |
| Coagulation | $XX Million | $XX Million | XX% |
| Histology | $XX Million | $XX Million | XX% |
| Hematology | $XX Million | $XX Million | XX% |
| Blood Grouping | $XX Million | $XX Million | XX% |
| Others | $XX Million | $XX Million | XX% |
| Total | $XX Million | $XX Million | XX% |
Source: Kalorama Information
